Valthos
PrivateLast Round
Seed
Oct 29, 2025
Total Funding Raised
$30M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Valthos operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Seed round in October 2025.
Valthos is a biotechnology and artificial intelligence company that develops software and AI systems to identify biological threats and design medical countermeasures.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Defense Tech, Drug Discovery
Business Model
B2G
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Valthos Comparables
Compare Valthos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Radical Numerics | 76% | |
| Red Queen Bio | 74% | |
| Perimeter Systems | 72% |
For institutional investors. Book with your work email.
Valthos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 29, 2025 | ||||
| Early Stage VC | Aug 14, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Valthos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Founders Fund | Seed |
| Lux Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Grew 27% QoQ from 11 to 14 employees.
- Jul 28, 2026
Grew 50% QoQ from 10 to 15 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 18, 2026
Valthos Inc. plans to develop an AI-based biodefense platform after securing $30 million in seed financing led by OpenAI and Lux Capital; the platform rapidly characterizes biological sequences and recommends medical countermeasures.
For institutional investors. Book with your work email.
Valthos Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Valthos's valuation, stock price, and market status.
Is Valthos a public or private company?
Valthos is a private company.
What is the current stock price of Valthos?
Valthos is a private company, so its shares have no public market price. Caplight tracks Valthos's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Valthos worth (valuation)?
Valuation information for Valthos is not publicly available.
Can I buy Valthos stock?
Valthos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Valthos's last funding round?
Valthos's most recent funding round was Seed on October 29, 2025.
Who are the main investors in Valthos?
Key investors in Valthos include Founders Fund, Lux Capital.
Will Valthos IPO soon?
No public IPO plans have been announced for Valthos.
How can I track Valthos secondary market activity?
Caplight tracks bids, offers, and trades in Valthos's shares on secondary markets.